1. Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020. Issue 1 (5th March 2022) Authors: Bakker, Elisabeth; Hendrikse, Natalie M.; Ehmann, Falk; van der Meer, Daniëlla S.; Llinares Garcia, Jordi; Vetter, Thorsten; Starokozhko, Viktoriia; Mol, Peter G.M. Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Marketing authorisation of orphan medicines in Europe from 2000 to 2013. Issue 2 (February 2018) Authors: Hofer, Matthias P.; Hedman, Hanna; Mavris, Maria; Koenig, Franz; Vetter, Thorsten; Posch, Martin; Vamvakas, Spiros; Regnstrom, Jan; Aarum, Stiina Journal: Drug discovery today Issue: Volume 23:Issue 2(2018) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗